Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edurne Arriola

Showing results (31-40 of 90) with videos related to

Pageof 9
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 30, 2016
ctDNA Determination of EGFR Mutation Status in European and Japanese Patients with Advanced NSCLC: The ASSESS StudyMartin Reck, Koichi Hagiwara, Baohui Han, et al.
Breast Cancer Research and Treatment|January 30, 2007
Topoisomerase II alpha amplification may predict benefit from adjuvant anthracyclines in HER2 positive early breast cancerEdurne Arriola, Socorro Maria Rodriguez-Pinilla, Maryou B K Lambros, et al.
British Journal of Clinical Pharmacology|November 3, 2010
Preliminary efficacy and safety of an oromucosal standardized cannabis extract in chemotherapy-induced nausea and vomitingMarta Duran, Eulàlia Pérez, Sergio Abanades, et al.
Oncology and Therapy|January 15, 2022
Addition of Immune Checkpoint Inhibitors to Chemotherapy vs Chemotherapy Alone as First-Line Treatment in Extensive-Stage Small-Cell Lung Carcinoma: A Systematic Review and Meta-AnalysisEdurne Arriola, María González-Cao, Manuel Domine, et al.
Oncotarget|June 5, 2015
MET expression and copy number heterogeneity in nonsquamous non-small cell lung cancer (nsNSCLC)David Casadevall, Javier Gimeno, Sergi Clavé, et al.
Histopathology|August 11, 2017
CD274 (PDL1) and JAK2 genomic amplifications in pulmonary squamous-cell and adenocarcinoma patientsSergi Clavé, Lara Pijuan, David Casadevall, et al.
JTO Clinical and Research Reports|September 30, 2021
Comparison of Different Methods for Defining Hyperprogressive Disease in NSCLCPedro Rocha, Didac Ramal, Enric Ripoll, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|December 16, 2006
Evaluation of Phi29-based whole-genome amplification for microarray-based comparative genomic hybridisationEdurne Arriola, Maryou B K Lambros, Chris Jones, et al.
Frontiers in Immunology|May 2, 2022
CD33 Expression on Peripheral Blood Monocytes Predicts Efficacy of Anti-PD-1 Immunotherapy Against Non-Small Cell Lung CancerClaire Olingy, Ahmad Alimadadi, Daniel J Araujo, et al.
Clinical Lung Cancer|April 17, 2018
Dynamics of EGFR Mutation Load in Plasma for Prediction of Treatment Response and Disease Progression in Patients With EGFR-Mutant Lung AdenocarcinomaÁlvaro Taus, Laura Camacho, Pedro Rocha, et al.
Pageof 9

Showing results (31-40 of 90) with videos related to

Sort By:
Pageof 9
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 30, 2016
ctDNA Determination of EGFR Mutation Status in European and Japanese Patients with Advanced NSCLC: The ASSESS StudyMartin Reck, Koichi Hagiwara, Baohui Han, et al.
Breast Cancer Research and Treatment|January 30, 2007
Topoisomerase II alpha amplification may predict benefit from adjuvant anthracyclines in HER2 positive early breast cancerEdurne Arriola, Socorro Maria Rodriguez-Pinilla, Maryou B K Lambros, et al.
British Journal of Clinical Pharmacology|November 3, 2010
Preliminary efficacy and safety of an oromucosal standardized cannabis extract in chemotherapy-induced nausea and vomitingMarta Duran, Eulàlia Pérez, Sergio Abanades, et al.
Oncology and Therapy|January 15, 2022
Addition of Immune Checkpoint Inhibitors to Chemotherapy vs Chemotherapy Alone as First-Line Treatment in Extensive-Stage Small-Cell Lung Carcinoma: A Systematic Review and Meta-AnalysisEdurne Arriola, María González-Cao, Manuel Domine, et al.
Oncotarget|June 5, 2015
MET expression and copy number heterogeneity in nonsquamous non-small cell lung cancer (nsNSCLC)David Casadevall, Javier Gimeno, Sergi Clavé, et al.
Histopathology|August 11, 2017
CD274 (PDL1) and JAK2 genomic amplifications in pulmonary squamous-cell and adenocarcinoma patientsSergi Clavé, Lara Pijuan, David Casadevall, et al.
JTO Clinical and Research Reports|September 30, 2021
Comparison of Different Methods for Defining Hyperprogressive Disease in NSCLCPedro Rocha, Didac Ramal, Enric Ripoll, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|December 16, 2006
Evaluation of Phi29-based whole-genome amplification for microarray-based comparative genomic hybridisationEdurne Arriola, Maryou B K Lambros, Chris Jones, et al.
Frontiers in Immunology|May 2, 2022
CD33 Expression on Peripheral Blood Monocytes Predicts Efficacy of Anti-PD-1 Immunotherapy Against Non-Small Cell Lung CancerClaire Olingy, Ahmad Alimadadi, Daniel J Araujo, et al.
Clinical Lung Cancer|April 17, 2018
Dynamics of EGFR Mutation Load in Plasma for Prediction of Treatment Response and Disease Progression in Patients With EGFR-Mutant Lung AdenocarcinomaÁlvaro Taus, Laura Camacho, Pedro Rocha, et al.
Pageof 9